Study of DISC-0974-201 in Participants With IBD and Anemia (NCT07368972)
RALLY-IBD: A Phase 2 Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of DISC-0974 in Participants With Inflammatory Bowel Disease and Anemia of Inflammation
🩺 Plain-English Summary (8th-Grade Level)
This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.
Who can join: Review the eligibility criteria below.
Location: One of a Kind Clinical Research Center, LLC — Scottsdale, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (14 Sites)
- One of a Kind Clinical Research Center, LLC — Scottsdale, Arizona
- UCLA Catche & Tamar Manoukian Division of Digestive Diseases — Los Angeles, California
- Dolphin Medical Research — Doral, Florida
- Clinical Research of Osceola, LLC — Kissimmee, Florida
- Anchor Medical Research, LLC — Miami, Florida
- Gastro Health - Galloway Care Center — Miami, Florida
- Ezy Medical Research, Co — Miami Lakes, Florida
- Guardian Angel Research, Inc — Tampa, Florida
- KAD Clinical Research — St Louis, Missouri
- Gastro Health - Cincinnati — Cincinnati, Ohio
- Gastro Health - Blue Ash Care Center — Cincinnati, Ohio
- University Gastroenterology Clinical Research Department — Providence, Rhode Island
- One of a Kind Clinical Research Center, LLC — Kingwood, Texas
- Siena Research Network — Sugar Land, Texas
📞 Contact the Study Coordinator
Phone: (617) 674-9274
Email: clinicaltrials@discmedicine.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Inflammatory Bowel Disease (IBD)
- Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease — Nashville, Tennessee
- Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease — Boston, Massachusetts
- VR Therapies for IBD — Los Angeles, California
- Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease — Boston, Massachusetts
- Visualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE) in Participants With Inflammatory Bowel Disease (IBD) — Nashville, Tennessee
- Evaluation of the SMART IBD App in Pediatric IBD — Cincinnati, Ohio
Explore by condition: All Inflammatory Bowel Disease (IBD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.